A more rigorous analysis of the epidemiological impact of vaccination for meningococcal disease is essential for proper health economic estimates.
Thus, even if we were measuring the correct symptoms, we could expect that our purely categorical disease would be hidden within a continuous symptom distribution.
Older knowledge, perhaps because it has been relocated to regions that are damaged by the disease process, does not fare as well.
In the past, authors stressed the greater variability of the disease's prognosis, clinical findings and cell morphology.
First, several simplifying assumptions surrounding the disease process and treatment were necessary to construct the model.
Instead, they focused on the dominant urban health discourse surrounding reducing the cases of contagious diseases and improving hygiene.
The interview included an open disease history, a checklist of signs and symptoms, and a structured questionnaire.
One factor that has not, to our knowledge, been explicitly examined is the role of specific symptoms and disease intensity on transmission.
The average annualized number of outpatient visits was substantially higher for each disease state compared with the number of inpatient episodes.
Some of these compounds have been detrimental to the environment, and all too often the disease organisms being targeted have developed resistance.
Over the past five years, outstanding progress has been made in the development of therapeutic strategies targeting these diseases.
The main limitations in treating metastatic disease include poor vector transduction efficiencies and difficulties in targeting remote tumour cells with systemic vector delivery.
Such risk factors are generally considered non-modifiable at the time of disease onset, but may be targets for preventative strategies in the future.
However, the use of such a powerful intervention may inhibit visits for milder diseases, possibly resulting in aggravation of the disease.
The number of breathless people is increasing as patients with all types of cardio-respiratory disease live longer.
Các quan điểm của các ví dụ không thể hiện quan điểm của các biên tập viên Cambridge Dictionary hoặc của Cambridge University Press hay của các nhà cấp phép.